Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase

Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11).

ESMO open·2022

Studies on the mechanism of fluoropyrimidine cytotoxicity in l1210 cells: correlation with inhibition of thymidylate synthetase but not with incorporation into RNA.

Pharmaceutical research·2013

Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib).

The pharmacogenomics journal·2012

TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials.

The pharmacogenomics journal·2011

Quantitative measurement of relative gene expression in human tumors.

Methods in molecular biology (Clifton, N.J.)·2011

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine.

Annals of oncology : official journal of the European Society for Medical Oncology·2006

Monocarboxylate transporters 1 and 4 in tumor lactate exchange: Molecular mechanisms, pharmacological inhibition, and therapeutic translation.

Biochemical pharmacology·2026

Overcoming drug delivery barriers to Unlock the therapeutic potential of conventional chemotherapy in glioblastoma.

Biochemical pharmacology·2026

Antibody-drug conjugates as promising platform for intrahepatic cholangiocarcinoma: molecular insights, drug-delivery challenges, and emerging therapeutic targets.

Biochemical pharmacology·2026

Ubiquitin-Like protein UBL1 orchestrates monocyte recruitment and pro-inflammatory macrophage activation in critical limb ischemia: Involving SUMOylation and stabilization of PER1.

Biochemical pharmacology·2026

Basis of the IgM cleavage activity of IgMDELsp and IgMDEMma.

Biochemical pharmacology·2026

Conformational allocation of mitofusin 2 in neuronal mitochondrial dynamics: Mechanisms and therapeutic targeting.

Biochemical pharmacology·2026

Flavonoid Enantiomers and Benzofurans With α-Glucosidase Inhibitory Activity From the Leaves of Morus alba.

Chirality·2026

A natural compound derivative targeting HADHA disrupts mitochondrial homeostasis and suppresses renal cell carcinoma.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Tryptoline stereoprobe elaboration identifies inhibitors of the GRPEL1-HSPA9 complex.

Nature chemical biology·2026

Bacillus subtilis controls mycotoxigenic coffee pathogens by volatile-mediated long-range chemical signaling and contact-dependent lipopeptide antagonism.

Microbiological research·2026

Related Experiment Videos

Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase

Related Concept Videos

Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11).

Studies on the mechanism of fluoropyrimidine cytotoxicity in l1210 cells: correlation with inhibition of thymidylate synthetase but not with incorporation into RNA.

Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib).

TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials.

Quantitative measurement of relative gene expression in human tumors.

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine.

Monocarboxylate transporters 1 and 4 in tumor lactate exchange: Molecular mechanisms, pharmacological inhibition, and therapeutic translation.

Overcoming drug delivery barriers to Unlock the therapeutic potential of conventional chemotherapy in glioblastoma.

Antibody-drug conjugates as promising platform for intrahepatic cholangiocarcinoma: molecular insights, drug-delivery challenges, and emerging therapeutic targets.

Ubiquitin-Like protein UBL1 orchestrates monocyte recruitment and pro-inflammatory macrophage activation in critical limb ischemia: Involving SUMOylation and stabilization of PER1.

Basis of the IgM cleavage activity of IgMDELsp and IgMDEMma.

Conformational allocation of mitofusin 2 in neuronal mitochondrial dynamics: Mechanisms and therapeutic targeting.

Flavonoid Enantiomers and Benzofurans With α-Glucosidase Inhibitory Activity From the Leaves of Morus alba.

A natural compound derivative targeting HADHA disrupts mitochondrial homeostasis and suppresses renal cell carcinoma.

Tryptoline stereoprobe elaboration identifies inhibitors of the GRPEL1-HSPA9 complex.

Bacillus subtilis controls mycotoxigenic coffee pathogens by volatile-mediated long-range chemical signaling and contact-dependent lipopeptide antagonism.

Related Experiment Videos

Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase

Related Concept Videos

Related Articles